Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:DJ
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:virus
gptkb:COVID-19_pandemic |
| gptkbp:affects |
potentially increased severity
|
| gptkbp:allows |
imposed by various countries
|
| gptkbp:associated_with |
gptkb:COVID-19
|
| gptkbp:clinical_trial |
ongoing for vaccine effectiveness
|
| gptkbp:community |
observed in various regions
|
| gptkbp:descendant |
B.1.1.28
|
| gptkbp:discovered_by |
gptkb:Brazil
|
| gptkbp:distributes |
respiratory droplets
|
| gptkbp:exported_to |
multiple countries
|
| gptkbp:feedback |
varies by location
|
| gptkbp:genetic_diversity |
gptkb:N501_Y
E484 K K417 T P.1 critical for monitoring higher than some other variants |
| gptkbp:has_authority_over |
emerging on its implications
|
| gptkbp:healthcare |
increased surveillance
analyzed by researchers. collected for analysis mask-wearing and social distancing necessary for managing cases |
| https://www.w3.org/2000/01/rdf-schema#label |
Gamma variant
|
| gptkbp:impact |
conducted by health agencies
assessed by epidemiologists |
| gptkbp:is_monitored_by |
ongoing by health organizations
essential for controlling outbreaks |
| gptkbp:is_recognized_by |
November 2020
|
| gptkbp:is_vulnerable_to |
reduced effectiveness
influenced by its mutations potentially complicates efforts varies by vaccine |
| gptkbp:origin |
monitored over time
linked to Amazonas state |
| gptkbp:provides_information_on |
recommended by health authorities
updated based on new findings |
| gptkbp:public_awareness |
increased due to media coverage
|
| gptkbp:receives_funding_from |
increased due to its significance
|
| gptkbp:related_model |
part of WHO's variant tracking system
|
| gptkbp:research |
ongoing to understand its behavior
|
| gptkbp:research_focus |
vaccine adaptation
|
| gptkbp:responds_to |
coordinated by WHO and CDC
|
| gptkbp:risk_factor |
higher transmissibility
|
| gptkbp:scientific_classification |
Variant of Concern
|
| gptkbp:side_effect |
increased hospitalizations
|
| gptkbp:social_responsibility |
studied globally
|
| gptkbp:symptoms |
similar to other COVID-19 variants
|
| gptkbp:track |
important for public health
critical for vaccine strategy |
| gptkbp:transmission |
human-to-human
|
| gptkbp:treatment |
may affect monoclonal antibody treatments
|
| gptkbp:variant |
compared to Alpha and Delta variants
studied for transmissibility and severity |